OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 6 days from acceptance to publication (median values for papers published in this journal in the first half of 2019, 1-2 days of FREE language polishing time is also included in this period).
Physical Activity and Older Adults. Intervention Programs.
Submission Deadline: May 15, 2020 (Open) (Open) Submit Now
José Ma Cancela Carral, PhD
1. Senior Lecturer, Faculty of Education and Sport Sciences, University of Vigo, Galicia, Spain
2. Member of Rede Galega de Investigación en Demencias (Galician Dementia Research Network), Galicia, Spain
Research Interests: Dementia; physical activity; physical exercise; cognitive aging; older adults; Parkinson's disease
About This Topic
Human life expectancy has been increasing remarkably, and that is why the general population of developed nations has reached 83.98 (Japan) or 83.24 (Spain) years on average. This represents a health as well as economic concern for these countries.
Physical activity, as WHO indicates, is a low-cost treatment which may result in physical, psychological and social benefits among older adults. Generally speaking, studies confirm it is the more active male and female older adults who show lower mortality risk rates in cases of coronary cardiopathy, hypertension, cerebrovascular accidents, type 2 diabetes, bowel and breast cancer, depression, as well as better functioning muscular and cardiorespiratory systems, and higher mass and body composition.
Nowadays there are innumerable physical activity programs for older adults but are their effects similar? Which intervention program is best? Are all programs applicable to all people? The aim of this special issue is to present the results and conclusions different researchers have found.